0000000000368772

AUTHOR

Géraldine Le Duc

showing 3 related works from this author

A top-down synthesis route to ultrasmall multifunctional Gd-based Silica nanoparticles for theranostic applications

2013

International audience; New, ultrasmall nanoparticles with sizes below 5 nm have been obtained. These small rigid platforms (SRP) are composed of a polysiloxane matrix with DOTAGA (1,4,7,10-tetraazacyclododecane-1-glutaric anhydride-4,7,10-triacetic acid)-Gd3+ chelates on their surface. They have been synthesised by an original top-down process: 1) formation of a gadolinium oxide Gd2O3 core, 2) encapsulation in a polysiloxane shell grafted with DOTAGA ligands, 3) dissolution of the gadolinium oxide core due to chelation of Gd3+ by DOTAGA ligands and 4) polysiloxane fragmentation. These nanoparticles have been fully characterised using photon correlation spectroscopy (PCS), transmission elec…

Magnetic Resonance SpectroscopySiloxanesGadoliniumtheranosticAnalytical chemistryContrast Mediachemistry.chemical_elementNanoparticle02 engineering and technologySubstance P010402 general chemistry01 natural sciencesCatalysisFluorescence spectroscopylaw.inventionHeterocyclic Compounds 1-RingMicroscopy Electron TransmissionDynamic light scatteringlawcancer[CHIM]Chemical SciencesChelationSpectroscopyElectron paramagnetic resonanceOrganic ChemistryGeneral ChemistryNuclear magnetic resonance spectroscopySilicon Dioxide021001 nanoscience & nanotechnologyMagnetic Resonance Imaging0104 chemical sciencesSpectrometry Fluorescencechemistrysilicananoparticlesgadolinium0210 nano-technologyRadiotherapy Image-GuidedNuclear chemistry
researchProduct

Ultrasmall Rigid Particles as Multimodal Probes for Medical Applications

2011

International audience; Ultrasmall but multifunctional: Rigid imaging particles that are smaller than 5 nm in size can be obtained in a top-down process starting from a core–shell structure (core=gadolinium oxide; shell=polysiloxane). They represent the first multifunctional silica-based particles that are sufficiently small to escape hepatic clearance and enable animal imaging by four complementary techniques.

Diagnostic ImagingMaleMaterials scienceGadoliniumShell (structure)Mice Nudechemistry.chemical_elementHepatic clearanceNanotechnology02 engineering and technology010402 general chemistry[ CHIM ] Chemical Sciences01 natural sciencesCatalysisMiceAnimalsHumansNanotechnology[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Particle SizeComputingMilieux_MISCELLANEOUS010405 organic chemistryAnimal imagingGeneral MedicineGeneral Chemistry021001 nanoscience & nanotechnologyRats0104 chemical sciences3. Good healthMice Inbred C57BLCore (optical fiber)chemistry[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]NanoparticlesFemale[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Gadolinium oxideParticle size0210 nano-technologyAngewandte Chemie International Edition
researchProduct

AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine.

2019

International audience; AGuIX® are sub-5 nm nanoparticles made of a polysiloxane matrix and gadolinium chelates. This nanoparticle has been recently accepted in clinical trials in association with radiotherapy. This review will summarize the principal preclinical results that have led to first in man administration. No evidence of toxicity has been observed during regulatory toxicity tests on two animal species (rodents and monkeys). Biodistributions on different animal models have shown passive uptake in tumours due to enhanced permeability and retention effect combined with renal elimination of the nanoparticles after intravenous administration. High radiosensitizing effect has been obser…

Radiation-Sensitizing AgentsGadoliniummedicine.medical_treatmentGadolinium02 engineering and technologyReview ArticlePharmacologyTheranostic NanomedicineMice0302 clinical medicineMelanomaBrain NeoplasmsMelanomaGeneral Medicine[CHIM.MATE]Chemical Sciences/Material chemistry[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences021001 nanoscience & nanotechnology3. Good health[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciencesNuclear Medicine & Medical ImagingRadiology Nuclear Medicine and imagingHead and Neck Neoplasms030220 oncology & carcinogenesisToxicity/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being[SDV.IB]Life Sciences [q-bio]/Bioengineering0210 nano-technologyClinical Scienceschemistry.chemical_element[SDV.CAN]Life Sciences [q-bio]/CancerEnhanced permeability and retention effect03 medical and health sciences/dk/atira/pure/subjectarea/asjc/2700/2741SDG 3 - Good Health and Well-being[SDV.CAN] Life Sciences [q-bio]/CancerIn vivo[CHIM.ANAL]Chemical Sciences/Analytical chemistrymedicineAnimalsHumansRadiology Nuclear Medicine and imaging[SDV.IB] Life Sciences [q-bio]/Bioengineeringbusiness.industryCancermedicine.diseaseRadiation therapyClinical trialchemistryNanoparticlesbusinessForecasting
researchProduct